Clinical trial
Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese…
NCT00259077 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00259077 |
|---|---|
| Title | Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population |
| Official title | A Double-blind, Randomised, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy of Omeprazole 20mg and 10mg od for the Four-week Treatment of Non-erosive Reflux Disease (NERD) With That of Placebo od and to Investigate Safety |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-erosive Reflux Disease |
| Intervention type | Drug |
| Interventions | Omeprazole |
| Enrollment | 270 |
| Start date | Oct 1, 2003 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Nov 29, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: